Not applicableNo Longer AvailableNCT01260779
What this trial is testing
Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors
Who this might be right for
Cutaneous or Subcutaneous Tumors Where There is no Comparable or SatisfactoryApproved Alternative Therapy
Provectus Biopharmaceuticals, Inc.